Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue for 4.5 Years
Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial − ...
Corporate news, industry updates, business trends, financial updates, market analysis, economic insights, company profiles, industry leaders, investment opportunities, business growth strategies, market research, technology advancements, entrepreneurship, sustainability initiatives, regulatory developments, mergers and acquisitions, emerging markets, global business news, sector-specific news, expert opinions.